Source: Mediators of Inflammation. Unidade: FM
Subjects: WESTERN BLOTTING, CITOMETRIA DE FLUXO, ESTRESSE OXIDATIVO, FATOR DE ATIVAÇÃO DE PLAQUETAS, MELANOMA (QUIMIOTERAPIA), PROGNÓSTICO, TERAPIA COMBINADA, EXPRESSÃO GÊNICA
ABNT
ONUCHIC, Ana Claudia et al. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, v. 2012, p. 1-6, 2012Tradução . . Disponível em: https://doi.org/10.1155/2012/175408. Acesso em: 30 abr. 2024.APA
Onuchic, A. C., Machado, C. M. L., Saito, R. F., Rios, F. J., Jancar, S., & Chammas, R. (2012). Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, 2012, 1-6. doi:10.1155/2012/175408NLM
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1155/2012/175408Vancouver
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1155/2012/175408